Moleculin Biotech financial statements

멀레큘린 바이오테크NASDAQ:MBRX · Nasdaq · Healthcare · sector #13
$0.4766-2.10%
2026-10-05 close

Moleculin Biotech's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$28M.

Reported results

Moleculin Biotech notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q